Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
2011 Standout
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats
2001
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
2009
The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors
2006
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
2013
Leptin revisited: its mechanism of action and potential for treating diabetes
2012
Challenges and Opportunities of Defining Clinical Leptin Resistance
2012
Constitutive Activity in Melanocortin-4 Receptor
2014
Structural Similarities and Differences between Amyloidogenic and Non-Amyloidogenic Islet Amyloid Polypeptide (IAPP) Sequences and Implications for the Dual Physiological and Pathological Activities of These Peptides
2013
Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance
2010
Melanocortin receptor signaling in RAW264.7 macrophage cell line
2005
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
2018 StandoutNobel
Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase
2006
Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy
2010
Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
2019
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi
2018
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
2014
Treatment of Obesity with Celastrol
2015 Standout
Hepatocellular carcinoma
2021 Standout
Molecular Dynamics Simulation for All
2018 Standout
Gut-Brain Cross-Talk in Metabolic Control
2017
Gut microbiome and health: mechanistic insights
2022 Standout
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
2014
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals
2008
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
2010
Functional Selectivity of Melanocortin 4 Receptor Peptide and Nonpeptide Agonists: Evidence for Ligand-Specific Conformational States
2005
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
2012 Standout
Non-alcoholic fatty liver disease
2021 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Inhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities but Not Inflammation and Injury in Mice
2014
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Leptin potentiates the anti-obesity effects of rimonabant
2011
Divergent Behavioral Roles of Angiotensin Receptor Intracellular Signaling Cascades
2005
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Equine Metabolic Syndrome
2010 Standout
Chronic cold exposure results in subcutaneous adipose tissue browning and altered global metabolism in Qinghai-Tibetan plateau pika (Ochotona curzoniae)
2018 StandoutNobel
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Dietary Flavonoids Differentially Reduce Oxidized LDL-Induced Apoptosis in Human Endothelial Cells: Role of MAPK- and JAK/STAT-Signaling
2008
Gut hormones: Implications for the treatment of obesity
2009
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
Leptin at 14 y of age: an ongoing story
2009
CNS-targets in control of energy and glucose homeostasis
2009
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
2010 Standout
Invited review: Body condition score and its association with dairy cow productivity, health, and welfare
2009 Standout
What We Talk About When We Talk About Fat
2014 Standout
Cellular bioenergetics as a target for obesity therapy
2010
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
2014
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Leptin in human physiology and therapeutics
2010
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
2009
Leptin in humans: lessons from translational research
2009
Melanocortin-4 receptor–regulated energy homeostasis
2016
Exploring the full spectrum of macrophage activation
2008 Standout
NAFLD: A multisystem disease
2015 Standout
European Guidelines for Obesity Management in Adults
2015 Standout
The role of gut hormones in the regulation of body weight and energy homeostasis
2009
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
2009
Adipose Tissue as an Endocrine Organ
2004 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Gut Microbiota in Health and Disease
2010 Standout
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
2019
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Gut Peptides: Targets for Antiobesity Drug Development?
2009
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Pharmacological Approaches for the Treatment of Obesity
2002
Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin‐4 receptor knockout mouse
2008
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
2016
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Restoration of leptin responsiveness in diet‐induced obese mice using an optimized leptin analog in combination with exendin‐4 or FGF21
2012
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Disordered Eating Behavior in Individuals With Diabetes
2010
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
β-Arrestins and Cell Signaling
2007 StandoutNobel
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
2021
Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists
2016
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists
2017 StandoutNobel
Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD).
2016
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
2010
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
2017 Standout
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
2021
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake
2004
Targeting the gastrointestinal tract to treat type 2 diabetes
2016
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Obesity: global epidemiology and pathogenesis
2019 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
2013
Adipocytokines and the Metabolic Complications of Obesity
2008
Works of Jonathan D. Roth being referenced
Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms
2008
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
2008
Amylin: Pharmacology, Physiology, and Clinical Potential
2015
Role of oxidative stress in the increased activation of signal transducers and activators of transcription-3 in the fatty livers of obese Zucker rats
2004
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
2016
Interaction of Leptin and Amylin in the Long‐term Maintenance of Weight Loss in Diet‐induced Obese Rats
2009
Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
1999
Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight
2007
Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus
2003
Implications of Amylin Receptor Agonism
2009
Antiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression
2006
FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
2018
INT-767 improves histopathological features in a diet-inducedob/obmouse model of biopsy-confirmed non-alcoholic steatohepatitis
2018
Insights into amylin–leptin synergy
2010
Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats
2000
It Takes Two to Tango: Combined Amylin/Leptin Agonism as a Potential Approach to Obesity Drug Development
2009
Dexfenfluramine and norfenfluramine: comparison of mechanism of action in feeding and brain Fos-ir studies
2000
Role of Islet-, Gut-, and Adipocyte-Derived Hormones in the Central Control of Food Intake and Body Weight: Implications for an Integrated Neurohormonal Approach to Obesity Pharmacotherapy
2008
Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
2016
Combination Therapy with Amylin and Peptide YY[3–36] in Obese Rodents: Anorexigenic Synergy and Weight Loss Additivity
2007
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
2013
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
2012
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents
2014
Mechanisms of Amylin/Leptin Synergy in Rodent Models
2009